Equities

Novolog (pharm-up 1966) Ltd

NVLG:TLV

Novolog (pharm-up 1966) Ltd

Actions
Health CareHealth Care Providers
  • Price (ILa)152.30
  • Today's Change-0.70 / -0.46%
  • Shares traded80.47k
  • 1 Year change-12.97%
  • Beta0.6857
Data delayed at least 20 minutes, as of May 19 2024 13:49 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Novolog Pharm Up 1966 Ltd, formerly Pharm Up Ltd, is an Israel-based company, which operates in the health logistics sector. The Company is a logistical partner for domestic and multinational pharmaceutical and medical device companies operating in Israel. It mainly serves pharmacies, hospitals, and patients at home. The Company operates through its subsidiaries, which include: Care for Life-Professional Nurses Service, which provides a range of in-home services for patients by trained nurses and trained assistants, as well as Trialog-Clinical Trial Logistics, which specializes in logistics for clinical trials and works with pharmaceutical and Clinical Research Organization (CRO) companies that perform clinical trials in Israel.

  • Revenue in ILS (TTM)1.64bn
  • Net income in ILS-42.00m
  • Incorporated1966
  • Employees955.00
  • Location
    Novolog (pharm-up 1966) Ltd55 Maayan st.MODIIN 7171300IsraelISR
  • Phone+972 86604400
  • Fax+972 86604404
  • Websitehttps://www.novolog.co.il/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Oman Investment & Finance Co SAOG168.45m65.55m203.70m622.003.260.7172.821.210.0260.0260.06690.11850.1284--3.50--4.973.147.476.37----38.7320.790.4491--0.742137.490.18654.0739.5449.46-20.39-2.46
SAB Zenzele Kabili Holdings (RF) Ltd-20.42bn-20.42bn347.76m--------------------------------------------------------------
Generation Capital Ltd482.22m277.20m748.85m0.002.710.3596--1.550.21830.21830.37851.650.128--12.28--7.369.337.619.5591.3592.2557.4860.66--5.310.452--40.17304.1958.0070.75----
Novolog Pharm Up 1966 Ltd1.64bn-42.00m794.68m955.00--2.1410.570.4835-0.0823-0.08233.220.72660.62916.761.151,720,931.00-1.510.9452-6.394.2910.2911.03-2.401.640.85090.0840.35279.878.9912.55-188.41--19.37-7.28
Salam International Investment QPSC1.59bn46.68m810.27m1.12k17.360.54359.300.50870.04020.04021.371.280.34713.912.81--1.270.28391.720.42129.2326.223.670.84711.301.660.5668---3.31-10.28-31.07--2.14--
Data as of May 19 2024. Currency figures normalised to Novolog (pharm-up 1966) Ltd's reporting currency: Israeli Shekel ILS

Institutional shareholders

54.90%Per cent of shares held by top holders
HolderShares% Held
Migdal Makefet Pension & Provident Funds Ltd.as of 30 Sep 202370.40m13.79%
Phoenix Provident Fund Ltd.as of 30 Sep 202363.00m12.34%
Harel Provident Funds Ltd.as of 30 Sep 202362.21m12.18%
Clal Pension & Provident Funds Ltd.as of 30 Sep 202328.57m5.59%
Excellence Nessuah Mutual Funds Management Ltd.as of 30 Sep 202318.30m3.58%
Yelin Lapidot Mutual Fund Management Ltd.as of 29 Feb 202411.86m2.32%
Harel Mutual Funds Ltd.as of 30 Sep 20239.17m1.80%
Migdal Mutual Funds Ltd.as of 30 Sep 20237.78m1.52%
Meitav Mutual Funds Ltd.as of 29 Feb 20245.83m1.14%
Psagot Mutual Funds Ltd.as of 29 Feb 20243.28m0.64%
More ▼
Data from 29 Feb 2024 - 05 May 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.